Conexeu Sciences Inc.
Limited financial coverage for CNXU.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R.
- CEO
- Miles Harrison
- IPO
- 2026
- Employees
- 4
- HQ
- Reno, NV, US
Price Chart
- 52W High
- $18.79
- 52W Low
- $10.87
- 50D MA
- $13.93
- 200D MA
- $13.93
- Beta
- 0.00
- Avg Volume
- 93.25K
Get TickerSpark's AI analysis on CNXU
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 26, 26 | Wright Michael G. | other | 400,000 |
| May 26, 26 | Wright Michael G. | other | 400,000 |
| May 11, 26 | Wright Michael G. | other | 0 |
| May 11, 26 | Wright Michael G. | other | 0 |
| Jun 9, 25 | Wright Michael G. | other | 50,000 |
| Jan 21, 25 | Wright Michael G. | other | 78,595 |
| May 11, 26 | Wright Michael G. | other | 900,000 |
| May 22, 26 | Sharpe Jeffrey Nathan | other | 500,000 |
| May 22, 26 | Sharpe Jeffrey Nathan | other | 500,000 |
Our CNXU coverage
Recent articles, reports, and earnings notes.
Want a deeper read on CNXU?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
